Document ID: chunk:federal_register_of_legislation:F2023L00203:schedule:1:p3
Version: federal_register_of_legislation:F2023L00203
Segment Type: schedule
Provision Reference: sch 1 (pt 3/6)
Character Range: 11846–14792

103
11.0 Introduction 103
11.1 Male reproductive system 103
11.1.1 Male reproductive organs – penis 103
11.1.2 Male reproductive organs – scrotum 104
11.1.3 Male reproductive organs – testes, epididymes and spermatic cords 104
11.1.4 Male reproductive organs – prostate and seminal vesicles 105
11.2 Female reproductive system 105
11.2.1 Female reproductive organs – vulva and vagina 105
11.2.2 Female reproductive organs – cervix and uterus 106
11.2.3 Female reproductive organs – fallopian tubes and ovaries 107
Chapter 12 – The neurological system 108
12.0 Introduction 108
12.1 Disturbances of levels of consciousness and awareness 109
12.1.1 Permanent disturbances of levels of consciousness and awareness 109
12.1.2 Epilepsy, seizures and convulsive disorders 110
12.1.3 Sleep and arousal disorders 110
12.2 Impairment of memory, learning, abstract reasoning and problem solving ability 111
12.3 Communication impairments – dysphasia and aphasia 113
12.4 Emotional or behavioural impairments 114
12.5 Cranial nerves 115
12.5.1 The olfactory nerve (I) 115
12.5.2 The optic nerve, the oculomotor and trochlear nerves and the abducens (II, III, IV and VI) 115
12.5.3 The trigeminal nerve (V) 115
12.5.4 The facial nerve (VII) 116
12.5.5 The auditory nerve (VIII) 117
12.5.6 The glossopharyngeal, vagus, spinal accessory and hypoglossal nerves (IX, X, XI and XII) 118
12.6 Neurological impairment of the respiratory system 119
12.7 Neurological impairment of the urinary system 119
12.8 Neurological impairment of the anorectal system 119
12.9 Neurological impairment affecting sexual function 120
Chapter 13 – The haematopoietic system 121
13.0 Introduction 121
13.1 Anaemia 121
13.2 Leukocyte abnormalities or disease 121
13.3 Haemorrhagic disorders and platelet disorders 123
13.4 Thrombotic disorders 123
Division 2 – Assessment of the degree of non-economic loss suffered
by an employee as a result of an injury or impairment 124
Introduction 124
B1 Pain 125
B2 Suffering 126
B3 Loss of amenities 127
B4 Other loss 128
B5 Loss of expectation of life 128
B6 Calculation of non-economic loss 129
Division 3 – Calculation of the total entitlement to compensation for permanent impairment and non-economic loss 130
Appendix 1 – Combined values chart 131

LIST OF TABLES AND FIGURES

LIST OF TABLES
Table 1.1: Coronary artery disease 15
Table 1.2.1: Diastolic hypertension 17
Table 1.2.2: Systolic hypertension 18
Table 1.3: Arrhythmias 19
Table 1.4: Peripheral vascular disease of the lower extremities 19
Table 1.5: Peripheral vascular disease of the upper extremities 20
Table 1.6: Raynaud's disease 21
Table 2.1: Conversion of respiratory function values to impairment 23
Table 2.2: WPI derived from asthma impairment score 25
Table 2.4: WPI derived from obstructive sleep apnoea score 26
Table 3.1: Thyroid and parathyroid glands 27
Table 3.2: Adrenal cortex and medulla 28
Table 3.3: Pancreas (diabetes mellitus) 29
Table 3.4: Gonads and